Jeanna L. Welborn directs the Cytogenetics and Bone Marrow Labs and is an expert in myelodysplasia and leukemia. She concentrates on providing psychosocial support for patients through innovative therapies and outpatient disease management programs. Welborn's research encompasses study of acute leukemias, oncogenes, cytogenetics and molecular epidemiology of cancer.

Title:

Professor, Director, Cytogenetics Laboratory

Specialty:

Hematology and Oncology, Cancer, Internal Medicine, Pathology and Laboratory Medicine

Center/Program Affiliation:

Bone Marrow Transplant Program, UC Davis Comprehensive Cancer Center

Address:

UC Davis Comprehensive Cancer Center
4501 X St., Suite Second Floor
Sacramento, CA 95817

Phone:

(916) 734-5959

Education:

University of Texas, Southwestern Medical School
Dallas, Texas
M.D. 1982

Austin College
Sherman, Texas
B.A. 1976

Internships:

Good Samaritan Medical Center
Portland, Oregon
1982-85

Residency:

Good Samaritan Medical Center
Portland, Oregon
1983-85
Internal Medicine

Fellowships:

University of California, Davis Medical Center
Sacramento, California
1985-88
Hematology/Oncology

Board Certifications:

American Board of Medical Genetics, Clinical Cytogenetics, 1990
American Board of Internal Medicine, Hematology, 1988
American Board of Internal Medicine, Medical Oncology, 1987
American Board of Internal Medicine, 1985

Professional Memberships:

American Association for Cancer Research
American Association for the Advancement of Science
American College of Physicians
American Federation of Clinical Research
American Society of Clinical Oncology
American Society of Hematology
American Society of Human Genetics

Honors and Awards:

Who's Who of American Small Colleges, 1976
Honor Council of Austin College, 1975-76

Select Recent Publications:

Welborn J, Fenner S, Parks R. Features of polycythemia vera in the 8p12 myeloproliferative syndrome. Cancer Genet Cytogenet. 2010 May;199(1):53-5.

Welborn J, Fenner S, Parks R. Angioleiomyoma: a benign tumor with karyotypic aberrations. Cancer Genet Cytogenet. 2010 Jun;199(2):147-8.

Welborn J. Review: erythropoietin or darbepoetin for anemia in patients with cancer produces both benefits and harms with no increase in survival. ACP J Club. 2007 Jan-Feb;146(1):6.

Welborn J, Mack PC, Shi X-B. Cytogenetic Features of Acute Leukemia Presenting with Acute Liver Failure. 2006

Lakshmunarayanan R, konia T, Welborn J. Fibrous Hamartoma of Infancy: A Case Report with Associated Cytogenetic Findings. Archives of Pathology and Laboratory Medicine, 2005 Apr;129(4): 520-2.

Martel, C.L., Y. Li, L. Beckett, H. Chew, S. Christensen, A. Davies, K.S. Lam, D.H. Lau, F.J. Meyers, R.T. O'Donnell, C. Richman, S. Scudder, M. Tanaka, J. Tuscano, J. Welborn, T. Wun, D.R. Gandara, and P.N. Lara. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. The Cancer Journal, 2004 Sep-Oct;10(5): 294-300. 2004

Welborn J, Jenks H, Taplett J, Walling P. High-grade neuroendocrine carcinomas display unique cytogenetic aberrations. Cancer Genetics Cytogenetics, 2004 Nov;155(1): 33-41. 2004

Welborn, Jeanna. Acquired Robertsonian translocations are not rare events in acute leukemia and lymphoma. Cancer Genetics and Cytogenetics, 2004 May;151: 14-35. 2004

Welborn, Jeanna, Helen Jenks, Janet Taplett, and Paula Walling. inversion of chromosome 12 and lineage promiscuity in hematologic malignancies. Cancer Genetics and Cytogenetics, 2004 Jan 15;148(2): 91-103. 2004

Welborn, Jeanna. Constitutional chromosome aberrations as pathogenetic events in hematologic malignancies. Cancer Genetics and Cytogenetics, 2004 Mar;149(2): 137-153. 2004

To see if Jeanna Welborn is accepting new patients, or for assistance finding a UC Davis doctor, please call (800) 2-UC DAVIS.